
Annovis Bio 2020 Annual Meeting of Stockholders to Be Held on June 3, 2020
BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, will hold its 2020 Annual …
Read More